Serina Therapeutics
SER | AMEX
$1.42
+$0.03 (+2.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.48
+$0.06 (+4.23%)
After-hours:
Nov 16, 2026, 7:00 PM ET
+2.16%
(1D)No price chart data available for 1D timeframe.
Rating
33.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #699/1021 (Top 68%)
Key Statistics
Market Data
Market Cap $36.09M
1D Range
1.31 1.45
52W Range
1.28 4.26
Valuation (TTM)
PE -0.81
PB 2.59
EV/EBITDA -0.79
Valuation (NTM)
Forward PE N/A
Forward PEG 0.03
Price Target $8.00
Cash Flow
FCF Yield -63.2%
SBC Adj. FCF Yield -74.7%
SBC Impact -18.2%
Margins
Gross Margin -2650.4%
Operating Margin -21705.6%
FCF Margin -18246.4%
Growth (CAGR)
Revenue 3Y | 5Y 19.1% |
-27.4%
Dil EPS 3Y | 5Y 48.6% |
39.2%
FCF 3Y | 5Y -29.8% |
-36.2%
Returns
ROA -112.0%
ROE -195.0%
ROIC -156.4%
Financial Health
Net Cash
$16.23M
Current Ratio 4.62
Interest Coverage -65.22
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate inten...
Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Nov 28, 2018
Website www.serinatx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.31
Beat +8.30%
YoY:
+31.11% REV
$125K
Beat 0.00%
Next Earnings
Mar 30, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$8.00
Upside
+463.38%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SER